Receptors, Lysophosphatidic Acid
"Receptors, Lysophosphatidic Acid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subfamily of lysophospholipid receptors with specificity for LYSOPHOSPHATIDIC ACIDS.
| Descriptor ID |
D049368
|
| MeSH Number(s) |
D12.776.543.750.695.420.249
|
| Concept/Terms |
Receptors, Lysophosphatidic Acid- Receptors, Lysophosphatidic Acid
- Acid Receptors, Lysophosphatidic
- Lysophosphatidic Acid Receptors
- Lysophosphatidic Acid Receptor
- Acid Receptor, Lysophosphatidic
- LPA Receptors
- Receptors, LPA
- Receptor, Lysophosphatidic Acid
LPA2 Receptor- LPA2 Receptor
- Receptor, LPA2
- Edg-4 Receptor
- Edg 4 Receptor
- Receptor, Edg-4
- Edg4 Protein
LPA3 Receptor- LPA3 Receptor
- Receptor, LPA3
- Edg-7 Receptor
- Edg 7 Receptor
- Receptor, Edg-7
- EDG7 Protein
LPA1 Receptor- LPA1 Receptor
- Receptor, LPA1
- vzg-1 Receptor
- Receptor, vzg-1
- vzg 1 Receptor
- LPA-1 Receptor
- LPA 1 Receptor
- Edg2 Protein
- edg-2 Receptor
- Receptor, edg-2
- edg 2 Receptor
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Lysophosphatidic Acid".
Below are MeSH descriptors whose meaning is more specific than "Receptors, Lysophosphatidic Acid".
This graph shows the total number of publications written about "Receptors, Lysophosphatidic Acid" by people in this website by year, and whether "Receptors, Lysophosphatidic Acid" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 0 | 1 | 1 |
| 2000 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 7 | 7 |
| 2005 | 2 | 0 | 2 |
| 2006 | 1 | 3 | 4 |
| 2007 | 2 | 3 | 5 |
| 2008 | 4 | 1 | 5 |
| 2009 | 4 | 0 | 4 |
| 2010 | 1 | 3 | 4 |
| 2011 | 1 | 1 | 2 |
| 2012 | 1 | 2 | 3 |
| 2013 | 0 | 1 | 1 |
| 2015 | 1 | 0 | 1 |
| 2018 | 0 | 1 | 1 |
| 2021 | 1 | 0 | 1 |
| 2023 | 0 | 1 | 1 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Receptors, Lysophosphatidic Acid" by people in Profiles.
-
Loss of LPAR6 and CAB39L dysregulates the basal-to-luminal urothelial differentiation program, contributing to bladder carcinogenesis. Cell Rep. 2024 May 28; 43(5):114146.
-
Autotaxin suppresses cytotoxic T cells via LPAR5 to promote anti-PD-1 resistance in non-small cell lung cancer. J Clin Invest. 2023 09 01; 133(17).
-
Neural Crest-Like Stem Cell Transcriptome Analysis Identifies LPAR1 in Melanoma Progression and Therapy Resistance. Cancer Res. 2021 10 15; 81(20):5230-5241.
-
Ovarian cancer cell-derived lysophosphatidic acid induces glycolytic shift and cancer-associated fibroblast-phenotype in normal and peritumoral fibroblasts. Cancer Lett. 2019 02 01; 442:464-474.
-
Active YAP promotes pancreatic cancer cell motility, invasion and tumorigenesis in a mitotic phosphorylation-dependent manner through LPAR3. Oncotarget. 2015 Nov 03; 6(34):36019-31.
-
Genetic variation associated with circulating monocyte count in the eMERGE Network. Hum Mol Genet. 2013 May 15; 22(10):2119-27.
-
Virtual screening for LPA2-specific agonists identifies a nonlipid compound with antiapoptotic actions. Mol Pharmacol. 2012 Dec; 82(6):1162-73.
-
Role of the autotaxin-lysophosphatidate axis in cancer resistance to chemotherapy and radiotherapy. Biochim Biophys Acta. 2013 Jan; 1831(1):74-85.
-
Lysophosphatidic acid induces lymphangiogenesis and IL-8 production in vitro in human lymphatic endothelial cells. Am J Pathol. 2012 May; 180(5):2170-81.
-
Lysophosphatidic acid signaling protects pulmonary vasculature from hypoxia-induced remodeling. Arterioscler Thromb Vasc Biol. 2012 Jan; 32(1):24-32.